As uncontrolled sister chromatid separation is one of the hallmarks of malignant progression, it is expectable that PTTG1IP overexpression has previously been observed in malignancy, eg. in thyroid [6], breast [7] and colorectal carcinoma [8]. This evidence concerns the gene PTTG1IP and colorectal carcinoma.